These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36831504)

  • 1. c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53.
    Kaller M; Shi W; Hermeking H
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p.
    Chou J; Kaller M; Jaeckel S; Rokavec M; Hermeking H
    Mol Cancer; 2022 May; 21(1):120. PubMed ID: 35624466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
    Jackstadt R; Jung P; Hermeking H
    Cell Death Dis; 2013 Aug; 4(8):e775. PubMed ID: 23949224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP4 encodes a c-MYC-inducible repressor of p21.
    Jung P; Menssen A; Mayr D; Hermeking H
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
    Jackstadt R; Hermeking H
    Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c-MYC-AP4-p21 cascade.
    Jung P; Hermeking H
    Cell Cycle; 2009 Apr; 8(7):982-9. PubMed ID: 19270520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic AP4 expression induces cellular senescence via activation of p53 in long-term confluent retinal pigment epithelial cells.
    Wang Y; Wong MM; Zhang X; Chiu SK
    Exp Cell Res; 2015 Nov; 339(1):135-46. PubMed ID: 26439195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with
    Du Y; Rokavec M; Hermeking H
    Int J Biol Sci; 2023; 19(13):4103-4122. PubMed ID: 37705742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die.
    Wong MM; Joyson SM; Hermeking H; Chiu SK
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.
    Uxa S; Bernhart SH; Mages CFS; Fischer M; Kohler R; Hoffmann S; Stadler PF; Engeland K; Müller GA
    Nucleic Acids Res; 2019 Sep; 47(17):9087-9103. PubMed ID: 31400114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells.
    Wang Y; Cheng X; Samma MK; Kung SKP; Lee CM; Chiu SK
    Mol Cell Biochem; 2018 Jun; 443(1-2):193-204. PubMed ID: 29188535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulation: p53-p21-RB signaling.
    Engeland K
    Cell Death Differ; 2022 May; 29(5):946-960. PubMed ID: 35361964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.
    Engeland K
    Cell Death Differ; 2018 Jan; 25(1):114-132. PubMed ID: 29125603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.
    Hou Z; Guo K; Sun X; Hu F; Chen Q; Luo X; Wang G; Hu J; Sun L
    Mol Cancer; 2018 Dec; 17(1):172. PubMed ID: 30541550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells.
    Chou C; Pinto AK; Curtis JD; Persaud SP; Cella M; Lin CC; Edelson BT; Allen PM; Colonna M; Pearce EL; Diamond MS; Egawa T
    Nat Immunol; 2014 Sep; 15(9):884-93. PubMed ID: 25029552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.
    Chen S; Chiu SK
    Mol Cell Biochem; 2015 Sep; 407(1-2):57-68. PubMed ID: 26037074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.